China Pharma Holdings (CPHI) FCF Margin Growth (3y) (2013 - 2026)
China Pharma Holdings (CPHI) FCF Margin Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | 213.00 |
| 3 | Zoetis | 31.79 Bn | 30.11 Bn | 1.05 Bn | 2,102.00 |
| 4 | Takeda Pharmaceutical | 28.69 Bn | 22.89 Bn | 5.10 Bn | 180.00 |
| 5 | United Therapeutics | 22.25 Bn | 19.58 Bn | 683.80 Mn | 1,592.00 |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -291.00 |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn | -2,476.00 |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 1,604.00 |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | China Pharma Holdings | 42.13 Mn | 41.82 Mn | 83,566.00 | 1,584.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6,642.00 |
| Dec 31, 2025 | -859.00 |
| Sep 30, 2025 | -2,972.00 |
| Jun 30, 2025 | 6,149.00 |
| Mar 31, 2025 | 4,330.00 |
| Dec 31, 2024 | 3,172.00 |
| Sep 30, 2024 | 4,038.00 |
| Jun 30, 2024 | -3,585.00 |
| Mar 31, 2024 | -3,098.00 |
| Dec 31, 2023 | -2,061.00 |
| Sep 30, 2023 | 7,227.00 |
| Jun 30, 2023 | -866.00 |
| Mar 31, 2023 | -3,848.00 |
| Dec 31, 2022 | 2,332.00 |
| Sep 30, 2022 | -2,139.00 |
| Jun 30, 2022 | -4,662.00 |
| Mar 31, 2022 | -4,432.00 |
| Dec 31, 2021 | -3,352.00 |
| Sep 30, 2021 | -8,209.00 |
| Jun 30, 2021 | 4,140.00 |